TQ Quiz | Autoimmune Disease of Neuro-ophthalmic Significance: Myasthenia Gravis and Thyroid Eye Disease (Mackinac 2023) by Events@optometricedu.com | Aug 17, 2023 | 2023 Mackinac Island, TQ Courses | 0 comments "*" indicates required fields This field is hidden when viewing the form@{:35}This field is hidden when viewing the formDate (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent 60 days past date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date Difference (Hidden)1. Where is the location of the pathology in myasthenia gravis?* A - Brain B - Nerve C - Neuromuscular junction D - Muscle 2. Which of the following best describes the clinical presentation of myasthenia gravis?* A - Progression of clinical findings B - Stable clinical findings C - Variability over time D - Intermittent episodes of exacerbation and remission 3. Which of the following best describes the population of individuals affected by myasthenia gravis?* A - Younger men and older women B - Younger women and older men C - Younger men and younger women D - Older men and older women 4. Which of the following tissue substrates is the antigenic source of the autoimmune response of myasthenia gravis?* A - Thymus B - Heart C - Lung D - Kidney 5. Which receptor sites are vulnerable to the autoantibodies associated with myasthenia gravis?* A - Epinephrine B - Glutamate C - Calcium D - Acetylcholine 6. Which of the following muscles is least likely to be affected in myasthenia gravis?* A - Extraocular muscles B - Levator C - Iris sphincter D - Orbicularis oculi 7. All of the following are associated with generalized myasthenia gravis except:* A - Facial weakness B - Reduced hearing C - Neck weakness D - Abnormal speech tone 8. Myasthenic crisis is characterized by the combination of:* A - Diplopia and reduced vision B - Instability and confusion C - Difficulty breathing and swallowing D - Pain and impaired cognitive function 9. What is the most common eye sign associated with myasthenia gravis?* A - Ptosis B - Diplopia C - Incomplete lid closure D - Loss of vision 10. Which of the following is the best in-office optometric test to evaluate presumed myasthenic ptosis?* A - Single-fiber EMG B - Eyelid measurements C - Ice-pack test D - Intravenous Tensilon 11. Which of the following eye drops is effective in improving myasthenic ptosis?* A - Tropicamide B - Pilocarpine C - Prednisolone D - Oxymetazoline 12. Which of the following is true of thyroid eye disease?* A - Affects approximately 50% of individuals with Graves’ disease B - Typically develops within one year of hyperthyroidism onset C - Affects women more than men D - Commonly results in vision loss from optic neuropathy 13. Which of the following orbital structures are responsible for triggering the pathology of thyroid eye disease?* A - Fibroblasts B - Muscle C - Fat D - Optic nerve 14. Which of the following is a baseline finding used in the evaluation of thyroid eye disease in the Clinical Activity Score (CAS)?* A - Painful feeling behind the globe B - Increase in proptosis C - Decrease in visual acuity D - Decrease in eye movements 15. Which of the following is a characteristic feature of the proptosis associated with thyroid eye disease?* A - Variability over time B - Bilaterality C - Unilaterality D - Proptosis is very uncommon with thyroid eye disease 16. Which of the following extraocular rectus muscles is most commonly involved with thyroid eye disease?* A - Inferior B - Medial C - Superior D - Lateral 17. Which of the following thyroid function biomarkers is reduced in Graves’ disease?* A - T4 B - TSH C - TSI D - All of the above are reduced 18. What is the mechanism of action of teprotumumab in the treatment of thyroid eye disease?* A - Blocks TSH receptors B - Blocks IGF-1 receptors C - Sequesters T4 D - Downregulates thyroid gland activity 19. You are considering teprotumumab treatment for a patient with thyroid eye disease. Which of the following is an absolute contraindication?* A - Diabetes B - Hypertension C - Pregnancy D - Hyperthyroidism 20. Which of the following is the most significant modifiable risk factor in the management of a patient with thyroid eye disease?* A - Smoking B - Hypertension C - Obesity D - Hyperglycemia Personal InformationName* First Last Email* Phone*OE Tracker #License #Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationPromotional Code@{:35} | TQ Credit*After @{:59}, pricing will increase to $30. Price: (Past 60 Days) @{:35} | TQ CreditThis course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30. Price: Retake Discount Price: Promotional Discount Price: (Past 60 Days) Retake Discount Price: (Past 60 Days) Promotional Discount Price: Paying Via Credit Card A Paypal account is not required to pay using the button below. To pay using a credit card, click the Paypal button below. A new window will appear and a button "Pay with Debit or Credit Card" is available at the bottom of that window for your convenience. Payment MethodThis field is hidden when viewing the formCourse Information (HIDDEN)This field is hidden when viewing the formCourse Name (HIDDEN)This field is hidden when viewing the formRetake Code (HIDDEN)This field is hidden when viewing the formQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/)This field is hidden when viewing the formCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
